Hongqian Guo
机构：Nanjing Drum Tower Hospital, Nanjing University · ORCID：0000-0002-3121-5157
发表论文 560 篇 · 总被引 9768 次 · h-index 51
代表论文
- Biomimetic Copper Nanozyme Reprograms Cold Tumor via Cuproptosis–Pyroptosis Crosstalk for Potent Renal Carcinoma Immunotherapy (2025 · ACS Applied Materials & Interfaces · 被引 15)
- Plasma tsRNA Signatures Serve as a Novel Biomarker for Bladder Cancer (2025 · Cancer Science · 被引 10)
- 9MW2821, a novel Nectin-4 antibody-drug conjugate (ADC), combined with toripalimab in treatment-naïve patients with locally advanced or metastatic urothelial carcinoma (la/mUC): Results from a phase 1b/2 study. (2025 · Journal of Clinical Oncology · 被引 9)
- Fully automated volumetric assessment of tumor burden using artificial intelligence on 68Ga-PSMA-11 PET predicts survival after 177Lu-PSMA therapy in metastatic Castration-resistant prostate cancer (2025 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 8)
- The N6 ‐methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression (2025 · FEBS Journal · 被引 5)
- 68Ga-pentixafor PET/CT predict the surgical outcome for the primary aldosteronism (2025 · Clinical and Translational Imaging · 被引 2)